AI face scan could spot hidden heart disease

NCT ID NCT07277686

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence (AI) algorithm can screen for coronary artery disease (CAD) by analyzing facial images. Researchers will enroll 1,392 high-risk adults (those with diabetes, high blood pressure, or over 65) and use the AI to classify them as high or low risk. All participants will then undergo a CT scan of the heart to see if the AI's predictions match actual CAD. The goal is to see if this simple, non-invasive method can improve early detection in community settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI facial analysis algorithm
What this could lead to
If successful, this could provide a quick, non-invasive screening tool for coronary artery disease using just a facial photo.
What could go wrong
This is an early-stage study focused on screening accuracy, not treatment. The AI may not perform well in real-world settings or diverse populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE ALGORITHMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

    NOT_YET_RECRUITING

    Beijing, 100037, China

  • Zhoukou Chuanhui District Hospital of Traditional Chinese Medicine

    RECRUITING

    Zhoukou, Henan, 466000, China

  • Zhoukou Specialized Disease Hospital

    RECRUITING

    Zhoukou, Henan, 466000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.